导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -26.55% | 334/354 |
| 近一周 | -3.01% | 242/356 |
| 近一月 | -6.53% | 285/362 |
| 近一季 | -6.08% | 266/362 |
| 近半年 | -17.80% | 336/358 |
| 近一年 | -32.81% | 329/349 |
| 近两年 | 8.32% | 266/314 |
| 近三年 | 8.52% | 183/244 |
| 成立以来 | -4.74% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-17.74% 334/360 |
-14.33% 328/366 |
- - |
- - |
| 2025 | 28.71% 43/358 |
22.84% 27/340 |
-3.59% 311/348 |
26.17% 30/354 |
-13.86% 258/358 |
| 2024 | 21.39% 98/329 |
-2.48% 193/280 |
8.93% 35/310 |
28.89% 57/318 |
-11.35% 305/329 |
| 2023 | -11.01% 166/275 |
6.17% 64/205 |
-14.36% 205/230 |
-1.84% 23/262 |
-0.30% 157/276 |
| 2022 | -23.05% 115/201 |
-17.56% 114/153 |
6.25% 51/164 |
-24.15% 141/189 |
15.82% 42/202 |
| 2021 | -38.39% 96/150 |
-1.63% 253/312 |
-3.74% 297/328 |
-27.39% 319/358 |
-10.39% 129/151 |
| 2020 | 49.53% 2/103 |
-5.43% 80/280 |
28.53% 51/295 |
15.16% 15/299 |
6.83% 176/305 |
| 2019 | - - |
- - |
-6.57% 249/267 |
-4.62% 219/253 |
19.21% 5/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 易方达中证海外50ETF联接美元C VS. 建信富时100指数(QDII)人民币A(539003) |